Actualités Ampio Pharmaceuticals Inc (CE) - AMPE | Actions OTCMarkets

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Ampio Pharmaceuticals, Inc. Announces Appointment of New Chief Financial Officer to be Effective April 4, 2011

Ampio Pharmaceuticals, Inc. Announces Appointment of New Chief Financial Officer to be Effective April 4, 2011 PR Newswire GREENWOOD VILLAGE...

- Amended Current report filing (8-K/A)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) ...

- Small Company Offering and Sale of Securities Without Registration (D)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. FORM D OMB APPROVAL OMB Number: 3235-0076 Expires: June 30, 2012...

- Current report filing (8-K)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant...

- Current report filing (8-K)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant...

- Prospectus filed pursuant to Rule 424(b)(3) (424B3)

Table of Contents Filed pursuant to Rule 424(b)(3) File No. 333-171579 INFORMATION STATEMENT/PROSPECTUS...

- Current report filing (8-K)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant...

- Registration Statement for securities to be issued in business combination transactions (S-4/A)

Table of Contents As filed with the Securities and Exchange Commission on February 17, 2011...

- Annual Report (10-K)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark...

- Current report filing (8-K)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant...

- Registration Statement for securities to be issued in business combination transactions (S-4/A)

Table of Contents As filed with the Securities and Exchange Commission on January 13, 2011...

- Amended Current report filing (8-K/A)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 2 TO FORM 8-K ...

- Filing of certain prospectuses and communications in connection with business combination transactions (425)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 2 TO FORM 8-K ...

- Securities Registration: Business Combination (S-4)

Table of Contents As filed with the Securities and Exchange Commission on January 6, 2011...

- Filing of certain prospectuses and communications in connection with business combination transactions (425)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 1 TO FORM 8-K ...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Ampio Pharmaceuticals Inc (CE) (AMPE)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

AMPE Actualités

Ampio Pharmaceuticals, Inc. Announces Appointment of New Chief Financial Officer to be Effective April 4, 2011

- Amended Current report filing (8-K/A)

- Small Company Offering and Sale of Securities Without Registration (D)

- Current report filing (8-K)

- Current report filing (8-K)

- Prospectus filed pursuant to Rule 424(b)(3) (424B3)

- Current report filing (8-K)

- Registration Statement for securities to be issued in business combination transactions (S-4/A)

- Annual Report (10-K)

- Current report filing (8-K)

- Registration Statement for securities to be issued in business combination transactions (S-4/A)

- Amended Current report filing (8-K/A)

- Filing of certain prospectuses and communications in connection with business combination transactions (425)

- Securities Registration: Business Combination (S-4)

- Filing of certain prospectuses and communications in connection with business combination transactions (425)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Ampio Pharmaceuticals Inc (CE) (AMPE) Actualités

Ampio Pharmaceuticals Inc (CE) (AMPE)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

AMPE Actualités

Ampio Pharmaceuticals, Inc. Announces Appointment of New Chief Financial Officer to be Effective April 4, 2011

- Amended Current report filing (8-K/A)

- Small Company Offering and Sale of Securities Without Registration (D)

- Current report filing (8-K)

- Current report filing (8-K)

- Prospectus filed pursuant to Rule 424(b)(3) (424B3)

- Current report filing (8-K)

- Registration Statement for securities to be issued in business combination transactions (S-4/A)

- Annual Report (10-K)

- Current report filing (8-K)

- Registration Statement for securities to be issued in business combination transactions (S-4/A)

- Amended Current report filing (8-K/A)

- Filing of certain prospectuses and communications in connection with business combination transactions (425)

- Securities Registration: Business Combination (S-4)

- Filing of certain prospectuses and communications in connection with business combination transactions (425)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application